Skip to main content
OpenTrials

Clinical trial condition

Breast Neoplasms

Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.

9,789 public trials 1,783 recruiting studies
Refine in advanced search Browse all conditions

Breast Neoplasms trial results

Active, not recruiting

Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Chinese Men and Postmenopausal Women With Advanced Breast Cancer

NCT04544189

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +3 more
Locations
  • Novartis Investigative Site Hefei, Anhui, China
  • Novartis Investigative Site Hefei, Anhui, China
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Shijiazhuang, Hebei, China
View all 24 locations
View Trial Details
Active, not recruiting

Comparison of Fulvestrant (FASLODEX™) 250 mg and 500 mg in Postmenopausal Women With Oestrogen Receptor Positive Advanced Breast Cancer Progressing or Relapsing After Previous Endocrine Therapy.

NCT00099437

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Research Site Casa Grande, Arizona, United States
  • Research Site Fountain Valley, California, United States
  • Research Site New Britain, Connecticut, United States
  • Research Site Crystal River, Florida, United States
View all 106 locations
View Trial Details
Active, not recruiting

Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer

NCT01872260

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Univ of California at San Diego Moores Cancer Ctr San Diego, California, United States
  • UCSF Medical Center San Francisco, California, United States
  • H Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Massachusetts General Hospital SC-5 Boston, Massachusetts, United States
View all 25 locations
View Trial Details
Active, not recruiting

To Evaluate the Safety, Tolerability, and Pharmacokinetics of Inavolisib Single Agent in Participants With Solid Tumors and in Combination With Endocrine and Targeted Therapies in Participants With Breast Cancer

NCT03006172

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations
  • Massachusetts General Hospital. Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Columbia University Medical Center New York, United States
View all 13 locations
View Trial Details
Active, not recruiting

Genetic Analysis in Blood and Tumor Samples From Patients With Advanced or Metastatic Estrogen Receptor Positive and HER2 Negative Breast Cancer Receiving Palbociclib and Endocrine Therapy

NCT03281902

Conditions
Advanced Breast Carcinoma, Breast Diseases, Breast Neoplasms, +12 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
View Trial Details

Related conditions